Cargando…
Identification of neoantigens derived from alternative splicing and RNA modification
The acquisition of somatic mutations is the most common event in cancer. Neoantigens expressed from genes with mutations acquired during carcinogenesis can be tumor-specific. Since the immune system recognizes tumor-specific peptides, they are potential targets for personalized neoantigen-based immu...
Autores principales: | Park, Jiyeon, Chung, Yeun-Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korea Genome Organization
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6808645/ https://www.ncbi.nlm.nih.gov/pubmed/31610619 http://dx.doi.org/10.5808/GI.2019.17.3.e23 |
Ejemplares similares
-
ASNEO: Identification of personalized alternative splicing based neoantigens with RNA-seq
por: Zhang, Zhanbing, et al.
Publicado: (2020) -
AS-CMC: a pan-cancer database of alternative splicing for molecular classification of cancer
por: Park, Jiyeon, et al.
Publicado: (2022) -
Main Strategies for the Identification of Neoantigens
por: Gopanenko, Alexander V., et al.
Publicado: (2020) -
Dissection of molecular and histological subtypes of papillary thyroid cancer using alternative splicing profiles
por: Park, Jiyeon, et al.
Publicado: (2022) -
RNA Transcription and Splicing Errors as a Source of Cancer Frameshift Neoantigens for Vaccines
por: Shen, Luhui, et al.
Publicado: (2019)